Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression
暂无分享，去创建一个
[1] S. Svebak,et al. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. , 1990, The Journal of clinical psychiatry.
[2] C. de Montigny,et al. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. , 1990, The Journal of clinical psychiatry.
[3] S. Woods,et al. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs. , 1990, The Journal of clinical psychiatry.
[4] J. Schöpf. Treatment of Depressions Resistant to Tricyclic Antidepressants, Related Drugs or MAO-Inhibitors by Lithium Addition: Review of the Literature , 1989, Pharmacopsychiatry.
[5] D. Spiegel,et al. Treatment of tricyclic-resistant depression , 1989 .
[6] D. Wong,et al. Fluoxetine, a Highly Selective Serotonin Reuptake Inhibitor: A Review of Preclinical Studies , 1988, British Journal of Psychiatry.
[7] M. Lader. Long-term anxiolytic therapy: the issue of drug withdrawal. , 1987, The Journal of clinical psychiatry.
[8] D. Charney,et al. Variability of response to lithium augmentation in refractory depression. , 1986, The American journal of psychiatry.
[9] G. Klerman,et al. Long-term outcome of episodes of major depression. Clinical and public health significance. , 1984, JAMA.